Chung, Byunghoon
Ryu, Ik Hee
Lee, In Sik
Kim, Jin Kuk
Kim, Tae-im
Kim, Eung Kweon
Seo, Kyoung Yul
Jun, Ikhyun
Funding for this research was provided by:
Carl Zeiss Meditec AG
National Research Foundation of Korea (NRF-2021R1I1A1A01047951)
Yonsei University College of Medicine (6-2020-0222)
Korean Fund for Regenerative Medicine (KFRM 22C0615L1)
Article History
Received: 19 April 2022
Accepted: 13 September 2022
First Online: 24 September 2022
Competing interests
: Ik Hee Ryu and Jin Kuk Kim are executives of VISUWORKS, Inc. Ik Hee Ryu is a consultant and stockholder of Avellino Lab, USA, and a medical advisor of Avellino Lab Korea, Zeiss Meditec, and OCULUS Asia. The remaining authors have no proprietary or financial interest in the materials presented herein.